Search

everythinglearnresearchcommunity

for

Search:↓

The study's results on the effectiveness of low-dose IL-2 for alopecia areata and its impact on immune cells were not provided.

Using healthy donor stem cells can potentially calm overactive immune cells and reduce inflammation in severe hair loss patients, offering a possible treatment method.

Special immune cells called Tregs can help prevent lung scarring by blocking a specific growth factor.

Thymic transplantation normalized some T-cells but not others, maintaining immune function.

Inflammation plays a key role in activating skin stem cells for hair growth and wound healing, but more research is needed to understand how it directs cell behavior.

Using fat-derived stem cells with the drug meglumine antimoniate can help control skin disease and reduce parasites in mice with leishmaniasis.

Valproic Acid could potentially be used to treat immune-related conditions due to its ability to modify immune cell functions.

Mice with human fetal thymic tissue and stem cells developed symptoms similar to chronic graft-versus-host disease.

Increasing Treg cells in the skin does not cure hair loss from alopecia areata in mice.

Fetal skin has unique immune cells different from adult skin.

Jagged-1 in skin Tregs is crucial for timely wound healing by recruiting specific immune cells.

Immune cells are essential for skin regeneration using biomaterial scaffolds.

New findings suggest potential treatments for melanoma, hyperpigmentation, hair defects, and multiple sclerosis, and show skin microbiome changes don't cause atopic dermatitis.

Some cells may slow melanoma growth, a protein could affect skin pigmentation, a gene-silencing method might treat hair defects, skin bacteria changes likely result from eczema, and a defensin protein could help treat multiple sclerosis.

Cell therapy shows promise for treating severe psoriasis but needs more research to confirm safety and effectiveness.

Deleting Snai2 and Snai3 causes fatal autoimmunity.

MDSC-Exo can treat autoimmune alopecia areata and promote hair regrowth in mice.

Cellular and immunotherapies show promise for healing chronic wounds but need more research.

Alopecia areata involves both innate and adaptive immunity, with specific genes linked to the disease.

The combination of oral PUVA and corticosteroids helps regrow hair in severe alopecia areata.

Different parts of the body have unique immune characteristics in their skin.

Different immune responses cause hair loss in scalp diseases, with unique patterns in scalp psoriasis possibly protecting against hair loss.

IL-18 signaling helps mature Tregs move into the thymus.

IL-18 signaling helps mature Tregs move into the thymus.

Hair follicles are normally protected from the immune system, but when this protection fails, it can cause hair loss in alopecia areata.

A specific DNA region is crucial for Foxn1 gene expression in thymus cells but not in hair follicles.

Androgens may influence T cells, contributing to higher autoimmune liver disease risk in women.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

Blocking the CXCR3 receptor reduces T cell accumulation in the skin and prevents hair loss in mice.

A protein called EGFR protects hair follicle stem cells, and when it's disrupted, hair follicles can be damaged, but blocking certain pathways can restore hair growth.